Press Releases :: Rigel Pharmaceuticals, Inc. (RIGL)

Mar 14, 2007 7:30am EDT

Rigel Announces Presentation at the Lehman Brothers Global Healthcare Conference

Feb 13, 2007 7:30am EST

Rigel Announces Initiation of Phase 1 Study Evaluating R763 in Hematological Malignancies

Feb 07, 2007 7:30am EST

Rigel to Present at BIO CEO & Investor Conference 2007

Feb 06, 2007 7:30am EST

Rigel Announces Fourth Quarter and Year End 2006 Financial Results

Feb 01, 2007 7:30am EST

Rigel to Present at Upcoming Scientific Conferences

Jan 25, 2007 7:30am EST

Rigel Appoints Bradford S. Goodwin to Board of Directors

Jan 08, 2007 7:30am EST

Rigel Announces Initiation of Phase II Study Evaluating R788 in Immune Thrombocytopenic Purpura (ITP)

Jan 03, 2007 7:30am EST

Rigel to Present at Upcoming Keystone Symposium

Previous
1…
31
32
33
34
35
36
37
38
39
40